{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-102153","form_type":"8-K","ticker":"GRDN","cik":"0001802255","company_name":"Guardian Pharmacy Services, Inc.","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.221765+00:00","generated_at":"2026-05-15T14:56:31.940484+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Guardian Pharmacy Q4 revenue $397.6M (+17% YoY), net income $21.3M (+81%); raises 2026 EBITDA guidance","bullets":["Q4 diluted EPS $0.33, adjusted EPS $0.37; full-year diluted EPS $0.78, adjusted EPS $1.07.","Full-year revenue $1.45B (+18% YoY); net income $49.0M vs $71.0M loss in 2024.","2026 Adjusted EBITDA guidance raised to $120M–$124M (from $115M–$118M); revenue guidance unchanged $1.40B–$1.42B.","Cash $65.6M at year-end, no long-term debt outstanding under $75M credit facility.","Annualized return on equity approximately 27% in 2025; 54 full-service pharmacies after North Ridge acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-102153","json":"https://secwatch.observer/filing/0001193125-26-102153.json","markdown":"https://secwatch.observer/filing/0001193125-26-102153.md","text":"https://secwatch.observer/filing/0001193125-26-102153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/0001193125-26-102153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/d47713d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:56:31.940484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}